Picture of NANOSONICS logo

NAN — NANOSONICS News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Citi sees risk for Australia's Nanosonics being a one-product co

** Analysts at Citi believe Nanosonics  NAN.AX  remains
vulnerable to potential for increased competition as a
one-product company
    ** Broker maintains A$3.90/shr target price; maintains
"sell" rating
    ** Citi also sees risk for the infection prevention services
provider being vulnerable to newer technology that could make
their only product obsolete
    ** Should the impact of these factors be greater than
expected, the stock may have difficulty in achieving our
earnings estimates and valuation - Citi
    ** Three of eleven analysts rate stock "buy" or higher, five
rate "hold" and three rate "sell" or lower; their median PT is
A$4.73 - LSEG data
        ** Stock down 0.7% YTD, as of last close

 (Reporting by Shivangi Lahiri in Bengaluru)
 ((shivangi.lahiri@thomsonreuters.com))

Recent news on NANOSONICS

See all news